1. Home
  2. LYRA vs AMBO Comparison

LYRA vs AMBO Comparison

Compare LYRA & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • AMBO
  • Stock Information
  • Founded
  • LYRA 2005
  • AMBO 2000
  • Country
  • LYRA United States
  • AMBO United States
  • Employees
  • LYRA N/A
  • AMBO N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • AMBO Other Consumer Services
  • Sector
  • LYRA Health Care
  • AMBO Real Estate
  • Exchange
  • LYRA Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • LYRA 11.3M
  • AMBO 12.7M
  • IPO Year
  • LYRA 2020
  • AMBO 2010
  • Fundamental
  • Price
  • LYRA $6.37
  • AMBO $4.34
  • Analyst Decision
  • LYRA Hold
  • AMBO
  • Analyst Count
  • LYRA 1
  • AMBO 0
  • Target Price
  • LYRA $16.00
  • AMBO N/A
  • AVG Volume (30 Days)
  • LYRA 49.1K
  • AMBO 562.6K
  • Earning Date
  • LYRA 11-11-2025
  • AMBO 08-05-2025
  • Dividend Yield
  • LYRA N/A
  • AMBO N/A
  • EPS Growth
  • LYRA N/A
  • AMBO N/A
  • EPS
  • LYRA N/A
  • AMBO 0.69
  • Revenue
  • LYRA $770,000.00
  • AMBO $9,699,000.00
  • Revenue This Year
  • LYRA N/A
  • AMBO N/A
  • Revenue Next Year
  • LYRA $106.28
  • AMBO N/A
  • P/E Ratio
  • LYRA N/A
  • AMBO $6.40
  • Revenue Growth
  • LYRA N/A
  • AMBO 23.73
  • 52 Week Low
  • LYRA $3.81
  • AMBO $1.25
  • 52 Week High
  • LYRA $37.50
  • AMBO $6.75
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 39.68
  • AMBO 53.10
  • Support Level
  • LYRA $6.25
  • AMBO $3.47
  • Resistance Level
  • LYRA $7.30
  • AMBO $4.78
  • Average True Range (ATR)
  • LYRA 0.60
  • AMBO 0.63
  • MACD
  • LYRA -0.13
  • AMBO -0.05
  • Stochastic Oscillator
  • LYRA 8.98
  • AMBO 28.49

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: